期刊
ORGANIC PROCESS RESEARCH & DEVELOPMENT
卷 12, 期 6, 页码 1094-1103出版社
AMER CHEMICAL SOC
DOI: 10.1021/op8000614
关键词
-
A bulk enabling synthesis of the CCR-5 receptor antagonist, Maraviroc (UK-427,857) (1), is presented. Synthesis of the three key fragments, beta-amino ester 3, 4,4-difluorohexanecarboxylic acid (2), and 1,3,4-triazole-substituted tropane fragment 4 are described. Coupling strategies for these fragments are discussed and described, including synthetic challenges, protection strategies, impurity generation, and final scale-up of the developed route to 1.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据